Perampanel for the Reduction of Seizure Frequency in Patients With High-grade Glioma and Focal Epilepsy
Status:
Recruiting
Trial end date:
2023-01-15
Target enrollment:
Participant gender:
Summary
This phase IV trial studies the side effects and how well perampanel works in reducing
seizure frequency in patients with high-grade glioma and focal epilepsy. Perampanel is a drug
used to treat seizures. Giving perampanel together with other anti-seizure drugs may work
better in reducing seizure frequency in patients with high-grade glioma and focal epilepsy
compared to alternate anti-seizure drugs alone.